IBNSINA PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of ISPH for the last quarter is 12.24 B EGP, and it's 15.73% higher compared to the previous quarter. The net income of Q2 24 is 100.00 M EGP.